Design Therapeutics (DSGN) Assets (2020 - 2021)
Design Therapeutics' Assets history spans 2 years, with the latest figure at $400.4 million for Q3 2021.
- For Q3 2021, Assets changed N/A year-over-year to $400.4 million; the TTM value through Sep 2021 reached $400.4 million, changed N/A, while the annual FY2020 figure was $36.5 million, N/A changed from the prior year.
- Assets for Q3 2021 was $400.4 million at Design Therapeutics, down from $405.1 million in the prior quarter.
- Across five years, Assets topped out at $411.9 million in Q1 2021 and bottomed at $36.5 million in Q4 2020.